Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Yeaman is active.

Publication


Featured researches published by Michael Yeaman.


Antimicrobial Agents and Chemotherapy | 2006

Low-Level Resistance of Staphylococcus aureus to Thrombin-Induced Platelet Microbicidal Protein 1 In Vitro Associated with qacA Gene Carriage Is Independent of Multidrug Efflux Pump Activity

Arnold S. Bayer; Leon Iri Kupferwasser; Melissa H. Brown; Ronald A. Skurray; Steve Grkovic; Tiffanny Jones; K Mukhopadhay; Michael Yeaman

ABSTRACT Thrombin-induced platelet microbial protein 1 (tPMP-1), a cationic antimicrobial polypeptide released from thrombin-stimulated rabbit platelets, targets the Staphylococcus aureus cytoplasmic membrane to initiate its microbicidal effects. In vitro resistance to tPMP-1 correlates with survival advantages in vivo. In S. aureus, the plasmid-carried qacA gene encodes a multidrug transporter, conferring resistance to organic cations (e.g., ethidium [Et]) via proton motive force (PMF)-energized export. We previously showed that qacA also confers a tPMP-1-resistant (tPMP-1r) phenotype in vitro. The current study evaluated whether (i) transporters encoded by the qacB and qacC multidrug resistance genes also confer tPMP-1r and (ii) tPMP-1r mediated by qacA is dependent on efflux pump activity. In contrast to tPMP-1rqacA-bearing strains, the parental strain and its isogenic qacB- and qacC-containing strains were tPMP-1 susceptible (tPMP-1s). Efflux pump inhibition by cyanide m-chlorophenylhydrazone abrogated Etr, but not tPMP-1r, in the qacA-bearing strain. In synergy assays, exposure of the qacA-bearing strain to tPMP-1 did not affect the susceptibility of Et (ruling out Et-tPMP-1 cotransport). The following cytoplasmic membrane parameters did not differ significantly between the qacA-bearing and parental strains: contents of the major phospholipids; asymmetric distributions of the positively charged species, lysyl-phosphotidylglycerol; fatty acid composition; and relative surface charge. Of note, the qacA-bearing strain exhibited greater membrane fluidity than that of the parental, qacB-, or qacC-bearing strain. In conclusion, among these families of efflux pumps, only the multidrug transporter encoded by qacA conferred a tPMP-1r phenotype. These data suggest that qacA-encoded tPMP-1r results from the impact of a specific transporter upon membrane structure or function unrelated to PMF-dependent peptide efflux.


Platelets (Second Edition) | 2007

CHAPTER 40 – Antimicrobial Host Defense

Michael Yeaman; Arnold S. Bayer

Platelets have long been recognized for their role in maintaining hemostasis and contributing to wound healing. Yet platelets have historically been underappreciated for their multiple and integral functions in antimicrobial host defense. Structural and functional features continue to reinforce the concept that platelets have explicit functions in antimicrobial host defense. Platelets express a diverse array of constitutive and inducible membrane receptors. Thus, platelets have key attributes of sentinel cells that are highly sensitive and responsive to a broad spectrum of agonists associated with microbial contamination, infection, or tissue inflammation. Upon activation, platelets transform from quiescent discoid forms to amoeboid cells that recognize and adhere to microbial pathogens or ligands displayed by tissues injured by trauma or infection.


Archive | 2000

Antimicrobial peptides and derived metapeptides

Michael Yeaman; Alexander J. Shen


Archive | 2007

Pharmaceutical compositions and methods to vaccinate against mucosal candidiasis

John E. Edwards; Scott G. Filler; Ashraf S. Ibrahim; Yue Fu; Brad Spellberg; Michael Yeaman


Archive | 2007

Antimicrobial kinocidin compositions and methods of use

Nannette I. Yount; Michael Yeaman


Archive | 2007

Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents

John E. Edwards; Scott G. Filler; Ashraf S. Ibrahim; Yue Fu; Brad Spellberg; Michael Yeaman


Archive | 2012

HYR1-DERIVED COMPOSITIONS AND METHODS OF TREATMENT USING SAME

Ashraf S. Ibrahim; Michael Yeaman; John E. Edwards; Guanpingsheng Luo; Yue Fu


Archive | 2005

Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis

John E. Edwards; Scott G. Filler; Donald C. Sheppard; Ashraf S. Ibrahim; Yue Fu; Brad Spellberg; Michael Yeaman


Archive | 2003

Multifunctional context-activated protides and methods of use

Michael Yeaman; Nannette Y. Yount; John E. Edwards; Eric P. Brass


Archive | 2014

Anti-infective hydroxy-phenyl-benzoates and methods of use

Michael Yeaman; Arnold S. Bayer

Collaboration


Dive into the Michael Yeaman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yue Fu

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arnold S. Bayer

Los Angeles Biomedical Research Institute

View shared research outputs
Top Co-Authors

Avatar

Brad Spellberg

University of California

View shared research outputs
Top Co-Authors

Avatar

John P. Hennessey

Los Angeles Biomedical Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge